Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
Bringing together an active group of basic scientists and clinicians to identify novel therapeutic targets and develop translational research projects for treating heart disease.
Basic, translational and clinical research are covered by the journal to enhance insights into cardiovascular disease mechanisms and the perspective for innovation.
The Frontiers in CardioVascular Biomedicine meetings are increasingly considered as one of the most relevant exchange platforms for basic and translational cardiovascular biology.
29/04/2022 00:0001/05/2022 00:00Europe/ParisFrontiers in CardioVascular Biomedicine 2022
Our mission: To reduce the burden of cardiovascular disease.